Stayble Therapeutics AB's CEO presents the company and the rights issue
In connection with the ongoing rights issue, Stayble Therapeutics CEO Andreas Gerward makes a number of presentations and interviews. More information about the rights issue, where the subscription period runs until 12 April, see https://www.foretradesemission.staybletherapeutics.se/.Fill or Kill podcast, 28 March 2023. CEO Andreas Gerward participates in an interview in the podcast Fill or Kill. The episode is published via Swedish podcast applications and web services, such as Spotify, and can be heard on Stayble's website about the rights issue https://www.foretradesemission.